Report Overview
Report Summary
Eternity Insights can provide a deep dive research report highlighting the market and competitive in-telligence across the key segments of the market. The report also considers the impact of COVID-19 on the global Irritable Bowel Syndrome (IBS) market. The report considers 2018-2020 historic period, 2021 as base year, and 2022-2028 as forecast period. The report includes quantitative analysis of the market supported by the mar-ket drivers, challenges, and trends to accurately map the market scenario and competition.
Irritable Bowel Syndrome (IBS) market report is based on robust research methodology designed using blend of research ap-proaches developed using secondary/desk research and validated through the primary research and expert insights. Eternity Insights also uses paid data bases such as FACIVA, Hoovers, and other bench-marking and forecasting tools to provide accurate statistical analysis of supply and demand trends.
To learn more about this report
Key Research Highlights: Market Drivers
The Irritable Bowel Syndrome (IBS) market is estimated to expand at a considerable growth rate during the forecast period ow-ing to increasing prevalence of venous diseases and increasing new product approvals to cater this demand. Rise in the awareness about the diseases, increasing importance of early diagnosis, and growing spending on chronic diseases are poised to boost the market growth. Moreover, the key players in the market are investing in research and development of technologically advanced products leading to increased utilization of the Irritable Bowel Syndrome (IBS) products across developed and developing countries of the world.
Key Research Highlights: Market Restrains
Limited awareness about the diseases, high cost of products, low economical condition, and lack of favorable insurance systems restricts the adoption of Irritable Bowel Syndrome (IBS) products across developing regions of the globe. However, launch of new products with low cost and increasing efforts for market penetration in these regions can offer lucrative growth opportunities for the players in the Irritable Bowel Syndrome (IBS) market.
To learn more about this report
Key Research Highlights: Trends
Increasing research and development spending on Irritable Bowel Syndrome (IBS) development has been the leading industry trend of Irritable Bowel Syndrome (IBS) market
The leading players in the market are focused on developing products which are cost effective and high quality to tap the huge unaddressed opportunities in the developing regions. This can be wit-nessed from the increasing spending on research and development and growing number of new product approvals.
Global Irritable Bowel Syndrome (IBS) Market Size, 2018-2028 (USD MILLION)
To learn more about this report
Market Segmentation
| Report Attributes |
Details |
| The market size value in 2021 |
USD XX.XX Million |
| CAGR (2021 - 2028) |
XX.XX % |
| The Revenue forecast in 2028 |
USD XX.XX Million |
| Base year for estimation |
2021 |
| Historical data |
2018-2019 |
| Forecast period |
2022-2028 |
| Quantitative units |
- Revenue in USD Million
- CAGR from 2021 to 2028
|
| Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments covered |
By Type Outlook, Application Outlook, Regional Outlook |
| By Type Outlook |
Irritable Bowel Syndrome with Constipation,Irritable Bowel Syndrome with Diarrhea,Irritable Bowel Syndrome with alternating Constipationand Diarrhea, Other |
| By Application Outlook |
Hospitals,Clinics,Homecare settings, Other |
| Regional scope |
North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Country scope |
U.S., Canada, U.K., Germany, France, BENELUX, China, India, Japan, South Korea, Brazil, Saudi Arabia, UAE, Turkey |
| Key companies profiled |
Valeant Pharmaceuticals International,Sucampo Pharmaceuticals,Abbott Laboratories,Lexicon Pharmaceuticals,Salix Pharmaceuticals,Ironwood Pharmaceuticals,GlaxoSmithKline,Allergan |
| Customization Available |
Yes, the report can be tailored to meet your specific requirements. |
Key Market Players
- Valeant Pharmaceuticals International
- Sucampo Pharmaceuticals
- Abbott Laboratories
- Lexicon Pharmaceuticals
- Salix Pharmaceuticals
- Ironwood Pharmaceuticals
- GlaxoSmithKline
- Allergan
Irritable Bowel Syndrome (IBS) Market, By Type
- Irritable Bowel Syndrome with Constipation
- Irritable Bowel Syndrome with Diarrhea
- Irritable Bowel Syndrome with alternating Constipationand Diarrhea
- Other
Irritable Bowel Syndrome (IBS) Market, By Application
- Hospitals
- Clinics
- Homecare settings
- Other
Key Benefits To The Stake Holders
- Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
- Provision of market value (USD Billion) and volume (Tons) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Table Of Contents
Table Of Contents
Table of Contents
Global Irritable Bowel Syndrome (IBS) Market Report 2020, Forecast to 2027
1 Scope of the Study
1.1 Irritable Bowel Syndrome (IBS) Introduction
1.2 Research Programs
1.3 Analysis of Macroeconomic Indicators
1.4 Years Considered
1.5 Methodology
1.6 Data Source
1.7 Research Objectives
2 Irritable Bowel Syndrome (IBS) Industry Overview
2.1 Global Irritable Bowel Syndrome (IBS) Market Size (Million USD) Comparison by Regions (2020-2027)
2.1.1 Irritable Bowel Syndrome (IBS) Global Import Market Analysis
2.1.2 Irritable Bowel Syndrome (IBS) Global Export Market Analysis
2.1.3 Irritable Bowel Syndrome (IBS) Global Main Region Market Analysis
2.2 Market Analysis by Type
2.2.1 Irritable Bowel Syndrome with Constipation
2.2.2 Irritable Bowel Syndrome with Diarrhea
2.2.3 Irritable Bowel Syndrome with alternating Constipationand Diarrhea
2.3.2 Clinics
2.3.3 Homecare settings
2.4.2 Global Irritable Bowel Syndrome (IBS) Revenue and Market Share by Manufacturer (2018-2020)
2.4.3 Global Irritable Bowel Syndrome (IBS) Industry Concentration Ratio (CR5 and HHI)
2.4.4 Top 5 Irritable Bowel Syndrome (IBS) Manufacturer Market Share
2.4.5 Top 10 Irritable Bowel Syndrome (IBS) Manufacturer Market Share
2.4.6 Date of Key Manufacturers Enter into Irritable Bowel Syndrome (IBS) Market
2.4.7 Key Manufacturers Irritable Bowel Syndrome (IBS) Product Offered
2.4.8 Mergers & Acquisitions Planning
2.5 Irritable Bowel Syndrome (IBS) Historical Development Overview
2.6 Market Dynamics
2.6.1 Market Opportunities
2.6.2 Market Risk
2.6.3 Market Driving Force
2.6.4 Porter's Five Forces Analysis
3 Upstream and Downstream Market Analysis
3.1 Upstream Analysis
3.1.1 Macro Analysis of Upstream Markets
3.1.2 Key Players in Upstream Markets
3.1.3 Upstream Market Trend Analysis
3.1.4 Irritable Bowel Syndrome (IBS) Manufacturing Cost Analysis
3.2 Downstream Market Analysis
3.2.1 Macro Analysis of Down Markets
3.2.2 Key Players in Down Markets
3.2.3 Downstream Market Trend Analysis
3.2.4 Sales Channel, Distributors, Traders and Dealers
4 Global Irritable Bowel Syndrome (IBS) Market Size Categorized by Regions
4.1 Global Irritable Bowel Syndrome (IBS) Revenue, Sales and Market Share by Regions
4.1.1 Global Irritable Bowel Syndrome (IBS) Sales and Market Share by Regions (2015-2020)
4.1.2 Global Irritable Bowel Syndrome (IBS) Revenue and Market Share by Regions (2015-2020)
4.2 Europe Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2015-2020)
4.3 APAC Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2015-2020)
4.4 North America Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2015-2020)
4.5 South America Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2015-2020)
4.6 Middle East & Africa Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2015-2020)
5 Europe Irritable Bowel Syndrome (IBS) Market Size Categorized by Countries
5.1 Europe Irritable Bowel Syndrome (IBS) Sales, Revenue and Market Share by Countries
5.1.1 Europe Irritable Bowel Syndrome (IBS) Sales by Countries (2015-2020)
5.1.2 Europe Irritable Bowel Syndrome (IBS) Revenue by Countries (2015-2020)
5.1.3 Germany Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2015-2020)
5.1.4 UK Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2015-2020)
5.1.5 France Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2015-2020)
5.1.6 Russia Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2015-2020)
5.1.7 Italy Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2015-2020)
5.1.8 Spain Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2015-2020)
5.2 Europe Irritable Bowel Syndrome (IBS) Revenue (Value) by Manufacturers (2018-2020)
5.3 Europe Irritable Bowel Syndrome (IBS) Sales, Revenue and Market Share by Type (2015-2020)
5.3.1 Europe Irritable Bowel Syndrome (IBS) Sales Market Share by Type (2015-2020)
5.3.2 Europe Irritable Bowel Syndrome (IBS) Revenue and Revenue Share by Type (2015-2020)
5.4 Europe Irritable Bowel Syndrome (IBS) Sales Market Share by Application (2015-2020)
6 Asia-Pacific Irritable Bowel Syndrome (IBS) Market Size Categorized by Countries
6.1 Asia-Pacific Irritable Bowel Syndrome (IBS) Sales, Revenue and Market Share by Countries
6.1.1 Asia-Pacific Irritable Bowel Syndrome (IBS) Sales by Countries (2015-2020)
6.1.2 Asia-Pacific Irritable Bowel Syndrome (IBS) Revenue by Countries (2015-2020)
6.1.3 China Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2015-2020)
6.1.4 Japan Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2015-2020)
6.1.5 Korea Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2015-2020)
6.1.6 India Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2015-2020)
6.1.7 Southeast Asia Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2015-2020)
6.1.8 Australia Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2015-2020)
6.2 Asia-Pacific Irritable Bowel Syndrome (IBS) Sales and Revenue (Value) by Manufacturers (2018-2020)
6.3 Asia-Pacific Irritable Bowel Syndrome (IBS) Sales, Revenue and Market Share by Type (2015-2020)
6.3.1 Asia-Pacific Irritable Bowel Syndrome (IBS) Sales Market Share by Type (2015-2020)
6.3.2 Asia-Pacific Irritable Bowel Syndrome (IBS) Revenue and Revenue Share by Type (2015-2020)
6.4 Asia-Pacific Irritable Bowel Syndrome (IBS) Sales and Market Share by Application (2015-2020)
7 North America Irritable Bowel Syndrome (IBS) Market Size Categorized by Countries
7.1 North America Irritable Bowel Syndrome (IBS) Sales, Revenue and Market Share by Countries
7.1.1 North America Irritable Bowel Syndrome (IBS) Sales by Countries (2015-2020)
7.1.2 North America Irritable Bowel Syndrome (IBS) Revenue by Countries (2015-2020)
7.1.3 United States Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2015-2020)
7.1.4 Canada Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2015-2020)
7.1.5 Mexico Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2015-2020)
7.2 North America Irritable Bowel Syndrome (IBS) Revenue (Value) by Manufacturers (2018-2020)
7.3 North America Irritable Bowel Syndrome (IBS) Sales, Revenue and Market Share by Type (2015-2020)
7.3.1 North America Irritable Bowel Syndrome (IBS) Sales Market Share by Type (2015-2020)
7.3.2 North America Irritable Bowel Syndrome (IBS) Revenue and Revenue Share by Type (2015-2020)
7.4 North America Irritable Bowel Syndrome (IBS) Sales Market Share by Application (2015-2020)
8 South America Irritable Bowel Syndrome (IBS) Market Size Categorized by Countries
8.1 South America Irritable Bowel Syndrome (IBS) Sales, Revenue and Market Share by Countries
8.1.1 South America Irritable Bowel Syndrome (IBS) Sales by Countries (2015-2020)
8.1.2 South America Irritable Bowel Syndrome (IBS) Revenue by Countries (2015-2020)
8.1.3 Brazil Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2015-2020)
8.2 South America Irritable Bowel Syndrome (IBS) Revenue (Value) by Manufacturers (2018-2020)
8.3 South America Irritable Bowel Syndrome (IBS) Sales, Revenue and Market Share by Type (2015-2020)
8.3.1 South America Irritable Bowel Syndrome (IBS) Sales Market Share by Type (2015-2020)
8.3.2 South America Irritable Bowel Syndrome (IBS) Revenue and Revenue Share by Type (2015-2020)
8.4 South America Irritable Bowel Syndrome (IBS) Sales Market Share by Application (2015-2020)
9 Middle East and Africa Irritable Bowel Syndrome (IBS) Market Size Categorized by Countries
9.1 Middle East and Africa Irritable Bowel Syndrome (IBS) Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Irritable Bowel Syndrome (IBS) Sales by Countries (2015-2020)
9.1.2 Middle East and Africa Irritable Bowel Syndrome (IBS) Revenue by Countries (2015-2020)
9.1.3 GCC Countries Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2015-2020)
9.1.4 Turkey Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2015-2020)
9.1.5 Egypt Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2015-2020)
9.1.6 South Africa Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2015-2020)
9.2 Middle East and Africa Irritable Bowel Syndrome (IBS) Revenue (Value) by Manufacturers (2018-2020)
9.3 Middle East and Africa Irritable Bowel Syndrome (IBS) Sales, Revenue and Market Share by Type
9.3.1 Middle East and Africa Irritable Bowel Syndrome (IBS) Sales Market Share by Type (2015-2020)
9.3.2 Middle East and Africa Irritable Bowel Syndrome (IBS) Revenue and Revenue Share by Type (2015-2020)
9.4 Middle East and Africa Irritable Bowel Syndrome (IBS) Sales Market Share by Application (2015-2020)
10 Global Irritable Bowel Syndrome (IBS) Market Segment by Type
10.1 Global Irritable Bowel Syndrome (IBS) Revenue, Sales and Market Share by Type (2015-2020)
10.1.1 Global Irritable Bowel Syndrome (IBS) Sales and Market Share by Type (2015-2020)
10.1.2 Global Irritable Bowel Syndrome (IBS) Revenue and Market Share by Type (2015-2020)
10.2 Irritable Bowel Syndrome with Constipation Sales Growth Rate and Price
10.2.1 Global Irritable Bowel Syndrome with Constipation Sales Growth Rate (2015-2020)
10.2.2 Global Irritable Bowel Syndrome with Constipation Price (2015-2020)
10.3 Irritable Bowel Syndrome with Diarrhea Sales Growth Rate and Price
10.3.1 Global Irritable Bowel Syndrome with Diarrhea Sales Growth Rate (2015-2020)
10.3.2 Global Irritable Bowel Syndrome with Diarrhea Price (2015-2020)
10.4 Irritable Bowel Syndrome with alternating Constipationand Diarrhea Sales Growth Rate and Price
10.4.1 Global Irritable Bowel Syndrome with alternating Constipationand Diarrhea Sales Growth Rate (2015-2020)
10.4.2 Global Irritable Bowel Syndrome with alternating Constipationand Diarrhea Price (2015-2020)
11.1 Global Irritable Bowel Syndrome (IBS)Sales Market Share by Application (2015-2020)
11.2 Hospitals Sales Growth Rate (2015-2020)
11.3 Clinics Sales Growth Rate (2015-2020)
11.4 Homecare settings Sales Growth Rate (2015-2020)
12.1 Global Irritable Bowel Syndrome (IBS) Revenue, Sales and Growth Rate (2020-2027)
12.2 Irritable Bowel Syndrome (IBS) Market Forecast by Regions (2020-2027)
12.2.1 Europe Irritable Bowel Syndrome (IBS) Market Forecast (2020-2027)
12.2.2 APAC Irritable Bowel Syndrome (IBS) Market Forecast (2020-2027)
12.2.3 North America Irritable Bowel Syndrome (IBS) Market Forecast (2020-2027)
12.2.4 South America Irritable Bowel Syndrome (IBS) Market Forecast (2020-2027)
12.2.5 Middle East & Africa Irritable Bowel Syndrome (IBS) Market Forecast (2020-2027)
12.3 Irritable Bowel Syndrome (IBS) Market Forecast by Type (2020-2027)
12.3.1 Global Irritable Bowel Syndrome (IBS) Sales Forecast by Type (2020-2027)
12.3.2 Global Irritable Bowel Syndrome (IBS) Market Share Forecast by Type (2020-2027)
12.4 Irritable Bowel Syndrome (IBS) Market Forecast by Application (2020-2027)
12.4.1 Global Irritable Bowel Syndrome (IBS) Sales Forecast by Application (2020-2027)
12.4.2 Global Irritable Bowel Syndrome (IBS) Market Share Forecast by Application (2020-2027)
13 Analysis of Irritable Bowel Syndrome (IBS) Industry Key Manufacturers
13.1 Valeant Pharmaceuticals International
13.1.1 Company Details
13.1.2 Product Information
13.1.3 Valeant Pharmaceuticals International Irritable Bowel Syndrome (IBS) Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.1.4 Main Business Overview
13.1.5 Valeant Pharmaceuticals International News
13.2 Sucampo Pharmaceuticals
13.2.1 Company Details
13.2.2 Product Information
13.2.3 Sucampo Pharmaceuticals Irritable Bowel Syndrome (IBS) Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.2.4 Main Business Overview
13.2.5 Sucampo Pharmaceuticals News
13.3 Abbott Laboratories
13.3.1 Company Details
13.3.2 Product Information
13.3.3 Abbott Laboratories Irritable Bowel Syndrome (IBS) Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.3.4 Main Business Overview
13.3.5 Abbott Laboratories News
13.4 Lexicon Pharmaceuticals
13.4.1 Company Details
13.4.2 Product Information
13.4.3 Lexicon Pharmaceuticals Irritable Bowel Syndrome (IBS) Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.4.4 Main Business Overview
13.4.5 Lexicon Pharmaceuticals News
13.5 Salix Pharmaceuticals
13.5.1 Company Details
13.5.2 Product Information
13.5.3 Salix Pharmaceuticals Irritable Bowel Syndrome (IBS) Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.5.4 Main Business Overview
13.5.5 Salix Pharmaceuticals News
13.6 Ironwood Pharmaceuticals
13.6.1 Company Details
13.6.2 Product Information
13.6.3 Ironwood Pharmaceuticals Irritable Bowel Syndrome (IBS) Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.6.4 Main Business Overview
13.6.5 Ironwood Pharmaceuticals News
13.7 GlaxoSmithKline
13.7.1 Company Details
13.7.2 Product Information
13.7.3 GlaxoSmithKline Irritable Bowel Syndrome (IBS) Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.7.4 Main Business Overview
13.7.5 GlaxoSmithKline News
13.8 Allergan
13.8.1 Company Details
13.8.2 Product Information
13.8.3 Allergan Irritable Bowel Syndrome (IBS) Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.8.4 Main Business Overview
13.8.5 Allergan News
15 Appendix